GlassScriptPhysician profile
Brittney Elizabeth Grimes
NPI 1265911176
$826.64
in general payments reported to CMS, 2019-2025
11 companies · $764 in 2025
The $764 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.96 · 2024: $46.34 · 2025: $764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $233.10 | 2025 | Evenity, Otezla, Krystexxa |
| Abbvie INC. | $218.24 | 2025 | |
| Novo Nordisk INC | $161.48 | 2024-2025 | Wegovy |
| Pfizer INC. | $47.94 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $47.55 | 2025 | Caplyta |
| Lilly USA, LLC | $36.29 | 2024-2025 | Mounjaro |
| Dynavax Technologies Corporation | $19.17 | 2025 | Heplisav-B |
| Astrazeneca Pharmaceuticals LP | $16.35 | 2025 | Airsupra |
| Organon LLC | $16.27 | 2025 | Nexplanon |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.87 | 2025 | Jardiance |
| Eisai INC. | $14.38 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittney Grimes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.